US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 0.992
  • -0.002-0.23%
Trading Aug 28 13:59 ET
32.82MMarket Cap-751P/E (TTM)

Reviva Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-59.41%-8.48M
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
-73.30%-4M
Net income from continuing operations
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
19.24%-9.72M
-212.26%-10.98M
-119.22%-11.71M
6.97%-6.85M
-231.63%-28.26M
-226.75%-12.04M
-54.23%-3.52M
Operating gains losses
-143.90%-200.27K
-4,000.10%-456.18K
22.86%239.22K
-114.46%-66.76K
---139.08K
356.25%456.18K
87.50%-11.13K
112.24%194.71K
266.00%461.74K
--0
Depreciation and amortization
----
--0
----
----
----
----
--0
----
----
----
Change In working capital
-123.39%-774.99K
-268.83%-4.21M
-18.43%7.28M
-92.33%524.12K
969.79%4.59M
124.25%3.31M
-199.35%-1.14M
1,371.68%8.93M
16,759.26%6.83M
-469.82%-527.27K
-Change in prepaid assets
-136.79%-351.51K
4.19%-1.19M
-94.60%70.89K
-65.58%81.81K
-33.18%275.7K
73.18%955.53K
-1,227.05%-1.24M
176.55%1.31M
116.83%237.65K
24.43%412.62K
-Change in payables and accrued expense
-117.96%-423.48K
-3,054.68%-3.02M
-5.31%7.21M
-93.29%442.31K
558.62%4.31M
154.69%2.36M
-90.16%102.04K
652.64%7.62M
380.91%6.59M
-397.19%-939.89K
Cash from discontinued investing activities
Operating cash flow
-59.41%-8.48M
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
-73.30%-4M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-48.58%2.68M
-51.68%332K
325.69%33.17M
146,813.77%27.27M
0
5.21M
981,461.43%687.09K
-75.34%7.79M
-81.15%18.56K
7.77M
Net issuance payments of debt
72.02%-124.5K
-50.26%332K
--0
---222.5K
--0
---445K
--667.5K
--0
--0
--0
Net common stock issuance
----
----
253.69%27.49M
--27.49M
--0
----
----
-75.32%7.77M
--0
----
Proceeds from stock option exercised by employees
--0
--0
29,836.99%5.68M
--0
--0
--5.66M
27,890.00%19.59K
-80.74%18.97K
-81.15%18.56K
--333
Cash from discontinued financing activities
Financing cash flow
-48.58%2.68M
-51.68%332K
325.69%33.17M
146,813.77%27.27M
--0
--5.21M
981,461.43%687.09K
-75.34%7.79M
-81.15%18.56K
--7.77M
Net cash flow
Beginning cash position
6.38%11.97M
26.18%23.37M
-37.62%18.52M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
238.89%29.69M
-30.75%23.19M
-45.76%19.42M
Current changes in cash
-5,474.17%-5.8M
-56.85%-11.39M
143.41%4.85M
493.73%18.4M
-263.83%-6.18M
97.40%-103.97K
-15.92%-7.26M
-153.37%-11.17M
-22.83%-4.67M
263.33%3.77M
End cash Position
-44.60%6.18M
6.38%11.97M
26.18%23.37M
26.18%23.37M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
-37.62%18.52M
-30.75%23.19M
Free cash flow
-59.41%-8.48M
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
-73.30%-4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -59.41%-8.48M-47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M-73.30%-4M
Net income from continuing operations 32.87%-7.86M-8.49%-7.43M-38.92%-39.26M19.24%-9.72M-212.26%-10.98M-119.22%-11.71M6.97%-6.85M-231.63%-28.26M-226.75%-12.04M-54.23%-3.52M
Operating gains losses -143.90%-200.27K-4,000.10%-456.18K22.86%239.22K-114.46%-66.76K---139.08K356.25%456.18K87.50%-11.13K112.24%194.71K266.00%461.74K--0
Depreciation and amortization ------0------------------0------------
Change In working capital -123.39%-774.99K-268.83%-4.21M-18.43%7.28M-92.33%524.12K969.79%4.59M124.25%3.31M-199.35%-1.14M1,371.68%8.93M16,759.26%6.83M-469.82%-527.27K
-Change in prepaid assets -136.79%-351.51K4.19%-1.19M-94.60%70.89K-65.58%81.81K-33.18%275.7K73.18%955.53K-1,227.05%-1.24M176.55%1.31M116.83%237.65K24.43%412.62K
-Change in payables and accrued expense -117.96%-423.48K-3,054.68%-3.02M-5.31%7.21M-93.29%442.31K558.62%4.31M154.69%2.36M-90.16%102.04K652.64%7.62M380.91%6.59M-397.19%-939.89K
Cash from discontinued investing activities
Operating cash flow -59.41%-8.48M-47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M-73.30%-4M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -48.58%2.68M-51.68%332K325.69%33.17M146,813.77%27.27M05.21M981,461.43%687.09K-75.34%7.79M-81.15%18.56K7.77M
Net issuance payments of debt 72.02%-124.5K-50.26%332K--0---222.5K--0---445K--667.5K--0--0--0
Net common stock issuance --------253.69%27.49M--27.49M--0---------75.32%7.77M--0----
Proceeds from stock option exercised by employees --0--029,836.99%5.68M--0--0--5.66M27,890.00%19.59K-80.74%18.97K-81.15%18.56K--333
Cash from discontinued financing activities
Financing cash flow -48.58%2.68M-51.68%332K325.69%33.17M146,813.77%27.27M--0--5.21M981,461.43%687.09K-75.34%7.79M-81.15%18.56K--7.77M
Net cash flow
Beginning cash position 6.38%11.97M26.18%23.37M-37.62%18.52M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M238.89%29.69M-30.75%23.19M-45.76%19.42M
Current changes in cash -5,474.17%-5.8M-56.85%-11.39M143.41%4.85M493.73%18.4M-263.83%-6.18M97.40%-103.97K-15.92%-7.26M-153.37%-11.17M-22.83%-4.67M263.33%3.77M
End cash Position -44.60%6.18M6.38%11.97M26.18%23.37M26.18%23.37M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M-37.62%18.52M-30.75%23.19M
Free cash flow -59.41%-8.48M-47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M-73.30%-4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg